Trial Profile
Randomized Trial of Epoetin Alfa in Men With Hormone-Refractory Prostate Cancer and Anemia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Janssen Inc
- 12 Nov 2006 New trial record.